rs375212345

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_005334.3(HCFC1):​c.3903C>T​(p.Thr1301Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,210,474 control chromosomes in the GnomAD database, including 1 homozygotes. There are 125 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., 14 hem., cov: 25)
Exomes 𝑓: 0.00029 ( 1 hom. 111 hem. )

Consequence

HCFC1
NM_005334.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.17

Publications

0 publications found
Variant links:
Genes affected
HCFC1 (HGNC:4839): (host cell factor C1) This gene is a member of the host cell factor family and encodes a protein with five Kelch repeats, a fibronectin-like motif, and six HCF repeats, each of which contains a highly specific cleavage signal. This nuclear coactivator is proteolytically cleaved at one of the six possible sites, resulting in the creation of an N-terminal chain and the corresponding C-terminal chain. The final form of this protein consists of noncovalently bound N- and C-terminal chains. The protein is involved in control of the cell cycle and transcriptional regulation during herpes simplex virus infection. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
HCFC1 Gene-Disease associations (from GenCC):
  • methylmalonic acidemia with homocystinuria, type cblX
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant X-153954496-G-A is Benign according to our data. Variant chrX-153954496-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 387453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.17 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCFC1NM_005334.3 linkc.3903C>T p.Thr1301Thr synonymous_variant Exon 17 of 26 ENST00000310441.12 NP_005325.2 P51610-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCFC1ENST00000310441.12 linkc.3903C>T p.Thr1301Thr synonymous_variant Exon 17 of 26 1 NM_005334.3 ENSP00000309555.7 P51610-1
HCFC1ENST00000369984.4 linkc.3903C>T p.Thr1301Thr synonymous_variant Exon 17 of 26 5 ENSP00000359001.4 A6NEM2

Frequencies

GnomAD3 genomes
AF:
0.000365
AC:
41
AN:
112422
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.0146
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000565
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000331
AC:
60
AN:
181034
AF XY:
0.000342
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000738
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000705
Gnomad OTH exome
AF:
0.000449
GnomAD4 exome
AF:
0.000286
AC:
314
AN:
1098052
Hom.:
1
Cov.:
34
AF XY:
0.000305
AC XY:
111
AN XY:
363468
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26401
American (AMR)
AF:
0.00
AC:
0
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19381
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30204
South Asian (SAS)
AF:
0.0000554
AC:
3
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40470
Middle Eastern (MID)
AF:
0.00242
AC:
10
AN:
4137
European-Non Finnish (NFE)
AF:
0.000330
AC:
278
AN:
842017
Other (OTH)
AF:
0.000456
AC:
21
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000365
AC:
41
AN:
112422
Hom.:
0
Cov.:
25
AF XY:
0.000405
AC XY:
14
AN XY:
34574
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30952
American (AMR)
AF:
0.00
AC:
0
AN:
10807
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3523
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2676
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6298
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.000565
AC:
30
AN:
53072
Other (OTH)
AF:
0.00
AC:
0
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000781
Hom.:
4
Bravo
AF:
0.000378
EpiCase
AF:
0.000545
EpiControl
AF:
0.00142

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 05, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 07, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Methylmalonic acidemia with homocystinuria, type cblX Benign:1
Oct 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HCFC1: BP4, BP7, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.3
DANN
Benign
0.66
PhyloP100
1.2
PromoterAI
-0.020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375212345; hg19: chrX-153219947; API